Literature DB >> 3610322

Septicemia and endocarditis, 1965-1980, in a Swedish university hospital for infectious diseases.

I Julander.   

Abstract

A 16-year (1965-1980) retrospective clinical study of septicemia and endocarditis was performed at a hospital for infectious diseases. 634 patients (74.5%) had septicemia, 138 (16.2%) endocarditis and 79 (9.3%) suspected endocarditis. The mean age was 55 years, 472 were males and 379 females. Predisposing underlying conditions were recognized in 89.2%. Gram-positive cocci (62.3%) dominated over gram-negative rods (29.5%). The most common causative organisms of septicemia were Staphylococcus aureus (22.4%) and Escherichia coli (20.2%), and of endocarditis, S. aureus (47.1%) and alpha haemolytic streptococci (21.0%). The overall fatality rate was 17.7% and was highest in infections caused by gram-negative rods and S. aureus. In septicemia the rate was 15.3% and in endocarditis 37.0%. Unfavourable prognostic factors were high age, endocarditis and underlying conditions such as haematological diseases and various other factors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3610322     DOI: 10.1007/bf01646043

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  26 in total

1.  Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-72.

Authors:  L L Pelletier; R G Petersdorf
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

2.  A 10-year study of bacteremia.

Authors:  E Jansson
Journal:  Scand J Infect Dis       Date:  1971

3.  Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir.

Authors:  O Ringdén; A Heimdahl; B Lönnqvist; A S Malmborg; H Wilczek
Journal:  Lancet       Date:  1984-03-31       Impact factor: 79.321

4.  Bacteraemia in a London teaching hospital 1966-75.

Authors:  G T Williams; E T Houang; E J Shaw; S Tabaqchali
Journal:  Lancet       Date:  1976-12-11       Impact factor: 79.321

Review 5.  Bacterial endotoxins: chemical structure, biological activity and role in septicaemia.

Authors:  E T Rietschel; U Schade; M Jensen; H W Wollenweber; O Lüderitz; S G Greisman
Journal:  Scand J Infect Dis Suppl       Date:  1982

6.  Septicemia in a pediatric unit. A 20-year study.

Authors:  P Hänninen; P Terho; A Toivanen
Journal:  Scand J Infect Dis       Date:  1971

7.  Blood-brain barrier derangement in sepsis: cause of septic encephalopathy?

Authors:  B Jeppsson; H R Freund; Z Gimmon; J H James; M F von Meyenfeldt; J E Fischer
Journal:  Am J Surg       Date:  1981-01       Impact factor: 2.565

8.  The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis.

Authors:  M P Weinstein; J R Murphy; L B Reller; K A Lichtenstein
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

9.  Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981.

Authors:  M R Griffin; W R Wilson; W D Edwards; W M O'Fallon; L T Kurland
Journal:  JAMA       Date:  1985-09-06       Impact factor: 56.272

10.  Prognosis of native valve infective endocarditis: a review of 253 cases.

Authors:  V Malquarti; W Saradarian; J Etienne; H Milon; J P Delahaye
Journal:  Eur Heart J       Date:  1984-10       Impact factor: 29.983

View more
  3 in total

1.  Survey of Escherichia coli septicemia over a six-year period.

Authors:  F Vázquez; M C Mendoza; G Viejo; F J Méndez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

Review 2.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

Review 3.  Infective endocarditis epidemiology over five decades: a systematic review.

Authors:  Leandro Slipczuk; J Nicolas Codolosa; Carlos D Davila; Abel Romero-Corral; Jeong Yun; Gregg S Pressman; Vincent M Figueredo
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.